PMID-sentid Pub_year Sent_text comp_official_name comp_offsetprotein_name organism prot_offset 30464200-0 2018 Suppression of Hepatic Bile Acid Synthesis by a non-tumorigenic FGF19 analogue Protects Mice from Fibrosis and Hepatocarcinogenesis. Bile Acids and Salts 23-32 fibroblast growth factor 15 Mus musculus 64-69 30464200-1 2018 Critical regulation of bile acid (BA) pool size and composition occurs via an intensive molecular crosstalk between the liver and gut, orchestrated by the combined actions of the nuclear Farnesoid X receptor (FXR) and the enterokine fibroblast growth factor 19 (FGF19) with the final aim of reducing hepatic BA synthesis in a negative feedback fashion. Bile Acids and Salts 23-32 fibroblast growth factor 15 Mus musculus 233-260 30464200-1 2018 Critical regulation of bile acid (BA) pool size and composition occurs via an intensive molecular crosstalk between the liver and gut, orchestrated by the combined actions of the nuclear Farnesoid X receptor (FXR) and the enterokine fibroblast growth factor 19 (FGF19) with the final aim of reducing hepatic BA synthesis in a negative feedback fashion. Bile Acids and Salts 23-32 fibroblast growth factor 15 Mus musculus 262-267 30464200-1 2018 Critical regulation of bile acid (BA) pool size and composition occurs via an intensive molecular crosstalk between the liver and gut, orchestrated by the combined actions of the nuclear Farnesoid X receptor (FXR) and the enterokine fibroblast growth factor 19 (FGF19) with the final aim of reducing hepatic BA synthesis in a negative feedback fashion. Bile Acids and Salts 34-36 fibroblast growth factor 15 Mus musculus 233-260 30464200-1 2018 Critical regulation of bile acid (BA) pool size and composition occurs via an intensive molecular crosstalk between the liver and gut, orchestrated by the combined actions of the nuclear Farnesoid X receptor (FXR) and the enterokine fibroblast growth factor 19 (FGF19) with the final aim of reducing hepatic BA synthesis in a negative feedback fashion. Bile Acids and Salts 34-36 fibroblast growth factor 15 Mus musculus 262-267 30464200-1 2018 Critical regulation of bile acid (BA) pool size and composition occurs via an intensive molecular crosstalk between the liver and gut, orchestrated by the combined actions of the nuclear Farnesoid X receptor (FXR) and the enterokine fibroblast growth factor 19 (FGF19) with the final aim of reducing hepatic BA synthesis in a negative feedback fashion. Bile Acids and Salts 308-310 fibroblast growth factor 15 Mus musculus 233-260 30464200-1 2018 Critical regulation of bile acid (BA) pool size and composition occurs via an intensive molecular crosstalk between the liver and gut, orchestrated by the combined actions of the nuclear Farnesoid X receptor (FXR) and the enterokine fibroblast growth factor 19 (FGF19) with the final aim of reducing hepatic BA synthesis in a negative feedback fashion. Bile Acids and Salts 308-310 fibroblast growth factor 15 Mus musculus 262-267 30464200-6 2018 Expression of the BA synthesis rate-limiting enzyme Cyp7a1 is reduced in FGF19-M52-treated mice compared to the GFP-treated control group with consequent reduction of BA pool and hepatic concentration. Bile Acids and Salts 18-20 fibroblast growth factor 15 Mus musculus 73-78 30464200-6 2018 Expression of the BA synthesis rate-limiting enzyme Cyp7a1 is reduced in FGF19-M52-treated mice compared to the GFP-treated control group with consequent reduction of BA pool and hepatic concentration. Bile Acids and Salts 167-169 fibroblast growth factor 15 Mus musculus 73-78 30464200-8 2018 Our data bona fide suggest the therapeutic potential of targeting the FXR-FGF19 axis to reduce hepatic BA synthesis in the control of BA-associated risk of fibrosis and hepatocarcinoma development. Bile Acids and Salts 103-105 fibroblast growth factor 15 Mus musculus 74-79 30464200-8 2018 Our data bona fide suggest the therapeutic potential of targeting the FXR-FGF19 axis to reduce hepatic BA synthesis in the control of BA-associated risk of fibrosis and hepatocarcinoma development. Bile Acids and Salts 134-136 fibroblast growth factor 15 Mus musculus 74-79